Recon: FDA labels Novo’s Indiana plant out of compliance; WHO warns of surging antibiotic resistance

ReconReconBiologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States